DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy

Cardiac hypertrophy (CH) is an independent risk factor for cardiovascular diseases (CVDs). Mitigating or preventing CH is the most effective strategy for the treatment of CVDs. DanHong injection (DH) is a Chinese herbal medicine preparation (CHMP) widely used in clinical treatment of several CVDs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min-Yu, Guo, Fei-Fei, Wu, Hong-Wei, Yu, Yang-Yang, Wei, Jun-Ying, Wang, Shi-Feng, Zhang, Yu-Xin, Xian, Ming-Hua, Wu, Qing-Hua, Zhao, Bu-Chang, Li, Shi-You, Yang, Hong-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732736/
https://www.ncbi.nlm.nih.gov/pubmed/29262570
http://dx.doi.org/10.18632/oncotarget.21900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732736/
https://www.ncbi.nlm.nih.gov/pubmed/29262570
http://dx.doi.org/10.18632/oncotarget.21900

Ejemplares similares